Jesse Jackson urges Biden to release AstraZeneca vaccine doeses for India

At a news conference in Chicago, American civil rights activist Rev Jesse Jackson said he would speak to Biden to immediately release 60 million doses of AstraZeneca vaccines to India

AstraZeneca
Photo: Reuters
Press Trust of India Washington
2 min read Last Updated : May 07 2021 | 6:46 AM IST

A top American civil rights leader has urged President Joe Biden to release 60 million AstraZeneca vaccine doses for India, which is battling a devastating second wave of the coronavirus pandemic.

The AstraZeneca vaccine has not been approved by the US and is unlikely to be used by the Biden administration.

Biden had recently said that he intended to give AstraZeneca vaccines to other countries.

At a news conference in Chicago, American civil rights activist Rev Jesse Jackson said he would speak to Biden to immediately release 60 million doses of AstraZeneca vaccines to India.

Mass level vaccination is said to be the only cure to the current public health crisis in India, he said.

"They are human beings. As the wind blows, if we don't stop it today, it'll spread around the world, he said.

Expressing concern over the current situation in India, Rev Jackson said he will personally speak to the healthcare industry to donate oxygen concentrators and cylinders to India and follow up with the pharmaceutical giants to ensure therapeutic supplies to the country.

Other Indian Americans from the Chicago area echoed similar sentiments.

"It is everyone's duty to help India flatten this COVID-19 surge as we live in a world that cannot be separated by borders," said Dr Vijay Prabhakar, the chairman of American Association of Multiethnic Physicians.

"Based on the current projections some of the models are suggesting, there may be 1 million deaths by the end of August. As we know, that would be a tragic humanitarian crisis, said Dr Srinivas Reddy, the trustee of Chicago Medical Society.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Joe BidenCoronavirusAstraZenecaCoronavirus Vaccine

First Published: May 07 2021 | 6:16 AM IST

Next Story